C07D417/06

BIASED ADRENERGIC AGONISTS

Disclosed herein are compounds, compositions, and methods for selecting targeting β.sub.2AR receptors. The compounds, compositions, and methods may be used in the treatment of obstructive lung diseases.

Heterocyclic compounds as immunomodulators

Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections. ##STR00001##

Heterocyclic compounds as immunomodulators

Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections. ##STR00001##

FLUORESCENT SYSTEMS FOR BIOLOGICAL IMAGING AND USES THEREOF
20220347299 · 2022-11-03 ·

The invention discloses a dye sensitizer molecule taking triazole as a core and a preparation method of the dye sensitizer molecule. According to the dye molecule, a triazole ring is introduced to the design of a molecular structure, and the electronic absorption and transmission capability among D-pi-A dye molecules are greatly improved by substituting donors with different carbon chain lengths and receptors with triple bonds at the periphery, so that a novel triazole dye with high efficiency is obtained. The preparation method of the compound comprises: click chemical reaction, detrimethylsilyl reaction, Sonogashira coupling reaction and the like; and the prepared dye molecule can be applied to a dye-sensitive solar cell and can show favorable photoelectric conversion property so as to have wide application prospects on the aspects of energy development and utilization. In addition, the material also has liquid crystal property under a certain condition so as to also have a huge potential on the aspect of application to photoelectric devices.

FLUORESCENT SYSTEMS FOR BIOLOGICAL IMAGING AND USES THEREOF
20220347299 · 2022-11-03 ·

The invention discloses a dye sensitizer molecule taking triazole as a core and a preparation method of the dye sensitizer molecule. According to the dye molecule, a triazole ring is introduced to the design of a molecular structure, and the electronic absorption and transmission capability among D-pi-A dye molecules are greatly improved by substituting donors with different carbon chain lengths and receptors with triple bonds at the periphery, so that a novel triazole dye with high efficiency is obtained. The preparation method of the compound comprises: click chemical reaction, detrimethylsilyl reaction, Sonogashira coupling reaction and the like; and the prepared dye molecule can be applied to a dye-sensitive solar cell and can show favorable photoelectric conversion property so as to have wide application prospects on the aspects of energy development and utilization. In addition, the material also has liquid crystal property under a certain condition so as to also have a huge potential on the aspect of application to photoelectric devices.

POLYMORPHIC FORMS OF METOPIMAZINE
20230086867 · 2023-03-23 ·

Provided herein are novel polymorphic forms of metopimazine mesylate. These polymorphic forms are useful in methods, compositions, and kits for the treatment of an enteric nervous system disorder.

POLYMORPHIC FORMS OF METOPIMAZINE
20230086867 · 2023-03-23 ·

Provided herein are novel polymorphic forms of metopimazine mesylate. These polymorphic forms are useful in methods, compositions, and kits for the treatment of an enteric nervous system disorder.

THIORIDAZINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER
20220340554 · 2022-10-27 ·

The present invention relates to novel thioridazine analogue compounds of formula (I): wherein R.sub.1 is OCH.sub.3 or NH.sub.2, particularly suitable to be used in the treatment of pediatric acute myeloid leukemia harboring the t(6;11)(q27;q23) KMT2A/AFDN rearrangement.

##STR00001##

THIORIDAZINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER
20220340554 · 2022-10-27 ·

The present invention relates to novel thioridazine analogue compounds of formula (I): wherein R.sub.1 is OCH.sub.3 or NH.sub.2, particularly suitable to be used in the treatment of pediatric acute myeloid leukemia harboring the t(6;11)(q27;q23) KMT2A/AFDN rearrangement.

##STR00001##

RESPIRATORY VIRUS INHIBITORS

Disclosed herein are compounds which demonstrate activity against respiratory viruses, such as coronaviruses.